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ARTICLE
Xq28 duplication presenting with intestinal and
bladder dysfunction and a distinctive facial
appearance
Jill Clayton-Smith*,1, Sarah Walters1, Emma Hobson2, Emma Burkitt-Wright1,
Rupert Smith3, Annick Toutain4, Jeanne Amiel5, Stanislas Lyonnet5, Sahar Mansour6,
David Fitzpatrick7, Roberto Ciccone8, Ivana Ricca8,9, Orsetta Zuffardi8,10 and Dian Donnai1
1Medical Genetics Research Group and Regional Genetics Service, St Mary’s Hospital, Manchester, UK; 2Yorkshire
Regional Genetics Service, St James’s Hospital, Leeds, UK; 3Department of Paediatrics, Rochdale Infirmary, Rochdale,
UK; 4Department of Medical Genetics, CHU Clocheville, Tours, France; 5Inserm U781 et De´partement de Ge´ne´tique,
Hoˆpital Necker-Enfants, Malades, Paris, France; 6Department of Medical Genetics, St George’s University Hospital,
London, UK; 7MRC Human Genetics Unit, Western General Hospital, Edinburgh, UK; 8Genetica Medica, Universita` di
Pavia, Pavia, Italy; 9Istituto Neurologico C Mondino, Pavia, Italy; 10Policlinico San Matteo, Pavia, Italy
Xq28 duplications encompassing MECP2 have been described in male patients with a severe
neurodevelopmental disorder associated with hypotonia and spasticity, severe learning disability and
recurrent pneumonia. We identified an Xq28 duplication in three families where several male patients had
presented with intestinal pseudo-obstruction or bladder distension. The affected boys had similar
dysmorphic facial appearances. Subsequently, we ascertained seven further families where the proband
presented with similar features. We demonstrated duplications of the Xq28 region in five of these
additional families. In addition to MECP2, these duplications encompassed several other genes already
known to be associated with diseases including SLC6A8, L1CAM and Filamin A (FLNA). The two remaining
families were shown to have intragenic duplications of FLNA only. We discuss which elements of the Xq28
duplication phenotype may be associated with the various genes in the duplication. We propose that
duplication of FLNA may contribute to the bowel and bladder phenotype seen in these seven families.
European Journal of Human Genetics (2009) 17, 434–443; doi:10.1038/ejhg.2008.192; published online 15 October 2008
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Introduction
In 2005, Meins et al1 described a submicroscopic duplica-
tion of Xq28 in a male patient with Rett syndrome-
like features including developmental regression and
stereotypic hand movements. The authors also noted
dysmorphic features with a narrow mid-face. Subsequently,
further patients with duplications of the same region have
been described.2 – 7 Van Esch et al2 identified an Xq28
duplication in a male patient from a large X-linked mental
retardation family using array comparative genomic
hybridisation (aCGH). This prompted them to screen 17
further male patients with similar phenotypes and led to
the identification of similar duplications in male patients
from three families. The consistent features of the
phenotype described were severe mental retardation, axial
hypotonia, seizures, acquired spasticity and frequent
infections. It was noted that some of the affected male
patients had hypotonic facies, a flat nasal bridge and
prominent ears. Over 50 patients have now been reported
with Xq28 duplications varying in size from 0.2 Mb to
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larger scale duplications extending beyond Xq27.8 – 10 Most
have included the MECP2 and L1CAM genes. It has been
suggested that the Xq28 duplication phenotype might be
solely due to duplication of the MECP2 gene as patients
with duplications involving this region alone have been
reported with the same classical phenotype.1,4,5
We initially identified duplications in Xq28 using the
multiplex ligation-dependent probe amplification (MLPA)
technique in male patients from three families who
presented with X-linked mental retardation. We noted
that functional intestinal or bladder obstruction and
characteristic ‘pinched’ facies were prominent features of
affected male patients. We subsequently carried out more
detailed analysis of the Xq28 region using further extended
MLPA test kits or CGH using either 250K SNP chips or an
Agilent array in the original three families and in seven
further families with similar bowel and or facial pheno-
types. Gargiulo et al11 reported Filamin A (FLNA) mutations
in X-linked families with intestinal pseudo-obstruction;
four of the families in our study (families 1, 5, 8 and 9) had
previously been investigated by this group for FLNA
mutations with negative results. We confirmed that
affected male patients from these four families had a
duplication of the FLNA gene and hypothesise that FLNA
duplications may be associated with the presence of bowel
dysfunction in patients with Xq28 duplications. Bladder
dysfunction and/or dilatation was also observed in 4 of our
20 patients and although it is clearly associated with Xq 28
duplication, it seems to be a more variable feature of the




The main clinical features are also summarised in Table 1.
Family 1
Sibling 1. The second child born to a healthy couple who
already had a healthy daughter. He was born at full term
with a birth weight of 3 kg (49th centile). He was
hypotonic and failed to thrive in the neonatal period. He
had severe constipation, required regular enemas and had a
distended abdomen. In the first year, he developed seizures
and had frequent chest infections. He never learned to sit
or roll. He died at the age of 212 years of bronchopneumonia
and right-sided cardiac failure. At autopsy, generalised
distention of the large bowel, bladder and ureters were
noted. There was no major brain abnormality. Photographs
show that he had a small narrow nose and a prominent
forehead.
Sibling 2 (proband). The full brother of case 1, born at full
term with a birth weight of 2.6 kg (2nd centile). In the
neonatal period, he had recurrent intermittent bowel
obstruction and was profoundly hypotonic. Rectal biopsy
demonstrated normal neurons in the submucous and
myenteric plexuses. Occasional neurons were noted to
show nuclear and cytoplasmic vacuolation. He required
daily enemas, had marked abdominal distention (Figure 1)
and frequent chest infections. He had no speech and was
profoundly delayed; he sat independently at 3 years of age.
He had a small narrow nose and a prominent forehead with
visible veins. His weight and length were below the 3rd
Table 1 Comparison of clinical features of 20 males with MECP2 duplications
Family 1 2 3 4 5 6 7 8 9 10
Case 1 2 3 1 2 3 1 2 1 1 2 3 1 1 1 2 3 1 1 2
Features
Birth weight (kg) 3.0 2.6 2.6 2.7 2.7 ? 2.83 2.9 2.7 3.16 2.8 3.7 1.8 3rd% 3.97 3.8 3.8 3.55 ? ?
OFC centile ? 5–10 ? o0.4 o0.4 ? o3 ? 9 9 9 25 10 3 ? ? ? 50 ? ?
Pseudo-obstruction/
constipation
+ + + + + +  + + + + + + + + + + +  +
Bladder distension +      + +     +   a    
Mental retardation + + + + + + + + +  + + + +     + +
PVNH  b c NS NS NS d d c d  NS d c NS NS NS NS NS NS
Early hypotonia + + + +   + + + + + + + +      
Spasticity    + + +   +           
Thrombocytopaenia        e       + + ? +  
PDA               + + + +  
Seizures +   + + +   +  +  +      + 
Chest infections + + + + + + + + + + +  + +     + +
Dysmorphic facies + + + + + +/ + + + + + + + + +/ +/ +/  + +
Hand stereotypies   + +  +/   +           
NS, no scan; ?, not known.
aHydronephrosis.
bPresence of enlarged neurons.
cHigh signal intensity in periventricular white matter.
dAgenesis/partial agenesis of corpus callosum.
eMarrow hypoplasia.
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centile but the head circumference was between the 5th
and 10th centiles. He died of pneumonia at 9 years of age.
At autopsy, there was marked distension of the intestines.
The brain weight was within the normal range but
histological examination showed an increased number of
neurons that were larger than normal in the granular layer
of the cerebral cortex, basal ganglia, hippocampus and
lateral geniculate nuclei. The cerebellum showed marked
enlargement of the dentate nucleus.
Sibling 3. This boy had a different father to that of his two
older brothers. He was born at full term with a birth weight
of 2.6 kg (42nd centile). Initially, he fed well and gained
weight but was hypotonic. By 6 months, he was signifi-
cantly developmentally delayed and failing to thrive. At 16
months, he was unable to sit without support and had no
speech development. Constipation was severe requiring
daily enemas. Facially, he had a pinched nose and
prominent forehead with thin appearing skin. He required
a gastrostomy and fundoplication because of frequent
chest infections and reflux. He made hand-flapping and
hand-wringing movements reminiscent of those seen in
Rett syndrome. MECP2 mutation testing was negative. MRI
scan of his head showed high signal intensity in the
periventricular white matter adjacent to the posterior
horns of the lateral ventricles. The ventricular size,
configuration of the extracerebral CSF spaces, corpus
callosum and cerebellum were normal.
Family 2 A 16-year-old girl attended clinic with her
mother asking for ‘carrier testing’. Her two maternal half-
brothers (siblings 1 and 2) and her maternal aunt’s son all
had severe/profound developmental delay, constipation,
recurrent chest infections, allergic rhinitis and seizures. All
three died around 20 years of age from pneumonia. No
DNA samples were available. The mothers of the affected
boys were shown to have markedly skewed X inactivation.
The phenotypic similarities between this family and family
1 had been recognised by the clinicians concerned several
years before the molecular diagnosis.
Sibling 1. He was born at term weighing approximately
2.7 kg. He spent 10 days in the special-care baby unit with
poor feeding. He suffered from severe constipation. He had
severe/profound mental retardation and had seizures from
age 4 years. At 4 and 10 years, he functioned at a 10-month
level with an intelligence quota (IQ) estimated to be 20. He
never developed speech nor walked but was able to stand
with support. He had subluxation of his hips. He had
frequent hospital admissions for pneumonia. He remained
small with height, weight and head circumference below
0.4th centiles. He was dysmorphic with a long thin face,
down slanting palpebral fissures, a prominent nasal bridge
and long narrow nose. His fingers and feet were long. He
was described as double jointed at the shoulders and
elbows. He was diagnosed with cerebral palsy because of
increased tone. Dystonic movements were noted in his
hands.
Sibling 2. He was born at term weighing 2.7 kg. Develop-
mental delay was more severe than GD1. He smiled at
3 months, never sat unsupported and had no speech. He
also suffered from extreme constipation, seizures, recurrent
pneumonia and increased tone in his legs. He had four
long bone fractures after minimal injury. His growth
parameters and dysmorphic features were similar to his
brother’s.
Cousin 1. He was born after a complicated breech
delivery. His development and growth was less delayed
compared with his cousins’. He smiled at 4 weeks, sat at 7
months, crawled at 1 year and walked with a frame from 3
Figure 1 Photograph of the proband from family 1 demonstrating
extreme abdominal distension due to chronic intestinal pseudo-
obstruction. This child also shows characteristic facial features with
pinched nose and a prominent forehead.
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years. He never walked independently. His IQ was 30 at 13
years; however, at 18 years, he was said to be functioning at
the level of a 6-year-old child. He had no speech, seizures
from 12 years, extreme constipation and recurrent pneu-
monia. He had two long bone fractures. His growth
parameters were within the normal range. Photographs
demonstrated possible dystonic movements; his nose was
narrow but he was not strikingly dysmorphic.
Family 3
Sibling 1 (proband). A male child born at 42 weeks
gestation with a birth weight of 2.83 kg (9th centile)
presented with neonatal hypotonia. He fed poorly and
had oesophageal reflux for which he subsequently under-
went a fundoplication and gastrostomy. He required
catheterisation for urinary retention. He had several
episodes of right heart failure, treated with digoxin and
diuretics, and had repeated admissions for pneumonia
during infancy. He made very little developmental pro-
gress, and at 6 months he remained hypotonic and was
unable to sit unsupported. At the age of 16 months, all of
his growth parameters were below the 3rd centile. He
underwent extensive investigations including a full meta-
bolic screen but no specific cause was identified for his
problems. Serum lactate was slightly elevated at
3.19 mmol/l. An MRI scan showed delayed myelination
and absence of the anterior part of the corpus callosum. An
IVP revealed a large thick-walled bladder. He died from
recurrent respiratory problems at 3 years of age.
Sibling 2. The second affected male child in this family
was born at term weighing 2.9 kg (49th centile). He was
hypotonic at birth with a distended abdomen due to a large
trabeculated bladder that emptied following catheterisa-
tion. He was dysmorphic with a narrow nose, deep-set eyes,
small chin and unusual ears. He held his thumbs clasped
across his palms. CT scan revealed partial agenesis of the
corpus callosum and mild dilatation of the lateral, third
and fourth ventricles. He required fundoplication for
gastro-oesophageal reflux. He also required treatment for
constipation. He had recurrent bouts of pneumonia and
suffered from unexplained anaemia, prompting bone
marrow examination that showed some red cell hypopla-
sia. He made very little developmental progress before his
death from respiratory problems and cardiac failure at 10
months of age.
The mother of these two boys was healthy. She had three
further healthy children. She had several male siblings who
had died as infants. One of them was diagnosed with prune
belly syndrome and another had a grossly distended
bladder after birth.
Family 4
Proband. He was born by caesarean section for
breech presentation at 38 weeks gestation, weighing
2700 g (2nd–9th centile). He was breastfed poorly. From
6 months, he needed a nasopharyngeal airway and had
frequent chest infections and episodes of pneumonia. At 8
years, he requires oxygen because of low saturations. He
was hyotonic, sat at 13 months, has never walked and has
no words. He has severe constipation requiring daily
suppositories. Seizures began at 6 years; EEG showed an
excess of slow wave activity but no specific features and
MRI scan showed cerebral hypoplasia/atrophy with in-
creased size of the ventricles and incomplete myelination,
and there was an abnormal periventricular white matter
signal. His head circumference was on the 9th centile and
his weight on the 50th centile. He had spasticity of his
lower limbs with contractures at his hips and knees. He had
deep-set eyes, a narrow nose and a prominent chin; his skin
appeared pale and thin. He had cold red feet with poor
circulation. He walked with support with a wide-based gait,
and frequent hand flapping was observed. He was inves-
tigated extensively for a metabolic disorder with negative
results. A diagnosis of Angelman syndrome had also been
suggested, but methylation analysis of chromosome
15q11–13 and UBE3A mutation analysis were normal.
Family 5
Sibling 1. A male child born at full term to a healthy
mother who had learning problems at school. There were
normal birth parameters (OFC 33 cm, 9th centile; weight
3.160 kg, 25th centile; length 50 cm, 25th centile). He was
noted to have a patent common mesentery. He had major
feeding difficulties, chronic constipation and gastro-oeso-
phageal reflux. He was significantly hypotonic but sat
unaided at 9 months and walked at 24 months. He had
postnatal growth retardation (3 SD for weight and
height). OFC was 0.5 SD. At 4 years, he could say a few
words and was hyperactive. No spasticity was noted. His
facial appearance and other clinical features were similar to
those of the proband in this family (sibling 2, below).
Cerebral MRI studies revealed partial agenesis of the
posterior corpus callosum and cortical atrophy.
Sibling 2. He was born at term with normal birth
parameters (OFC 33.5 cm, weight 2.800 kg and length
48 cm, all equal to or 49th centile). He had chronic
constipation and gastro-oesophageal reflux. He was hypo-
tonic, developed head control at 4 months and walked
with aids at 30 months. He was diagnosed as having
pseudointestinal obstruction following rectal biopsy,
which ruled out Hirschsprung disease. He had frequent
chest infections and exhibited dysautonomia in these
episodes. He also had myoclonic epilepsy. At 3 years, his
height and OFC were 2 SD. He was considered to have an
autistic spectrum disorder, but he had no sleep disorder
and no spasticity. He was dysmorphic with hypertelorism,
frontal bossing, low nasal bridge, anteverted nares, everted
lower lip and small wide-spaced teeth. Investigations
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including brain MRI and auditory-evoked potentials,
chromosome studies and metabolic screening in plasma
and CSF were all normal. Screening for carbohydrate-
deficient glycoprotein disorders and RSK2 screening were
also negative.
Half-sibling 3. The half-brother of siblings 1 and 2 with
the same mother. He was born at term after a normal
pregnancy. His birth parameters were normal with an OFC
of 34 cm, weight 3700 g and length 51 cm (all between 25th
and 50th centiles). He showed normal postnatal growth,
but was hypotonic and did not gain head control until 4
months. He also has severe constipation.
Family 6
Proband. A male, the only child of healthy unrelated
parents, was born at 37 weeks gestation by caesarean
section with a birth weight of 1.800 g (o3rd centile).
Prenatal ultrasound had shown urinary bladder dilatation;
at birth he was noted to have right cryptorchidism and
abdominal ultrasound confirmed megacystis with mild
dilatation of the renal pelvis. He had severe feeding
difficulties, growth retardation and hypotonia. For the
first 2 years of life, he suffered from severe constipation.
Barium radiographs of the upper and lower gastrointestinal
tracts revealed dilated and hypotonic loops of the proximal
portion of the large bowel and a reduction in the diameter
of the distal portion. By the age of 5 years, bowel function
had improved. He acquired head control at 4 months of
age and was able to walk independently at 24 months of
age. At 7 years, he has normal height and weight and a
relatively small head circumference (1 SD); he is severely
retarded, has epilepsy, recurrent respiratory infections and
gastro-oesophageal reflux. Speech is limited to two to three
words and his behaviour is hyperactive. Cerebral MRI, at 2
years of age, showed enlargement of the cisterna magna,
mild hypoplasia of the cerebellar vermis, mild hypoplasia
of the corpus callosum and delayed myelination. Echocar-
diogram showed a bicuspid aortic valve with mild valvular
insufficiency. His face is hypotonic, his forehead is
prominent and he has a narrow nose and small mouth
with flat malar regions. His ears appear large.
Family 7
Proband. A male, the only child born to healthy unrelated
parents at 37 weeks by caesarian section performed for
foetal bradycardia. Birth measurements were around the
3rd centiles for length, weight and head circumference.
Prenatal ultrasound revealed intrauterine growth retarda-
tion from the twentieth week of pregnancy. In the first 2
years of life, he suffered from gastro-oesophageal reflux. He
achieved head control at the age of 12 months and
independent sitting at the age of 2 years. At 6 years, his
height, weight and head circumference are all below the
3rd centiles and he is severely mentally retarded. He is
hypotonic and not able to stand or walk independently
and has no speech. He has had recurrent respiratory
infections and has severe chronic constipation. Despite a
high-fibre diet and the use of glycerin suppositories, he has
his bowels open only once or twice a week. He has
plagiocephaly, a prominent forehead, sparse eyebrows
and short palpebral fissures. His malar regions appear flat
and his nose small; the philtrum is short and he has a
pointed chin. MRI revealed periventricular leucomalacia.
Ophthalmological examination showed bilateral astigma-
tism and exotropia.
Family 8 A family with three affected male patients with
chronic neurogenic intestinal pseudo-obstruction, thromb-
cytopaenia, PDA, malrotation and characteristic facies and
without mental retardation previously reported.12 Linkage
was demonstrated to markers at Xq28.
Family 9
Proband. The first child born to a 35-year-old mother and
a 32-year-old father. In pregnancy, dilated loops of bowel
and a large cisterna magna were detected by ultrasound
scan. He was born at 40 weeks gestation with a birth weight
of 3.555 kg, length 51 cm and OFC 36 cm (all B50th
centile). A single umbilical artery and mild dilatation of the
renal pelvis were present. He had a wide patent ductus
arteriosus and a patent foramen ovale leading to heart
failure at 13 days. He underwent ligation of the patent
ductus at 16 days. He developed intestinal obstruction and
was found to have bowel malrotation with Ladd’s bands.
These were divided, but his intestinal obstruction persisted
and a second operation revealed dilatation of the small
bowel without mechanical cause. He was treated by
ileostomy and parenteral nutrition. Intestinal biopsies
excluded Hirschsprung’s disease but suggested a neuro-
genic cause for the bowel obstruction. Thrombocytopaenia
was also present (43–97 109/l) with the presence of giant
platelets and anisomegakaryocytes. He was not facially
dysmorphic. His features were considered very similar to
those of family 6 before the current investigations were
undertaken.
Family 10
Proband. The second child born to healthy parents, who
is currently aged 20 years. He was born following a normal
pregnancy, but development was delayed and he walked at
the age of 6 years. He has never developed speech. He had
feeding difficulties and in the first years of life he had
chronic diarrhoea. He has poor coordination, sleep dis-
order and autistic features. He has a seizure disorder that
began at the age of 13 years. He has hypothyroidism and
has suffered from frequent severe respiratory infections.
More recently, he has had two episodes of septicaemia, one
resulting in amputation of his left leg. On clinical
examination at the age of 20 years he has facial hypotonia,
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down-slanting palpebral fissures, hypoplastic alae nasi, a
high-arched palate, arachnodactyly, joint hyperlaxity and
scoliosis.
Sibling 1. He is the brother of the proband. He showed
severe psychomotor delay from birth and was noted to
have dysmorphic facial features. He suffered from severe
constipation, and despite a high-fibre diet and enemas, he
defaecated only twice a week. He died at the age of 18
months following a severe infection.
The proband had three other siblings. Two of these were
born healthy (one subsequently died as a result of trauma).
The remaining sibling, a girl, who was the twin of sibling 1
above, had a mild learning difficulty and attention
problems.
Cytogenetic and molecular analyses MLPA was
performed on genomic DNA isolated from peripheral blood
samples using the Gentra Puregene kit (Qiagen, Valencia,
CA, USA). The MLPA method used was as described
by Schouten et al,13 using MLPA kits purchased from
MRC-Holland (Amsterdam, the Netherlands). Initial MLPA
studies of the Xq28 region were performed using the P015C
kit and included probes for four exons of MECP2, IRAK1,
L1CAM, IDH3G and SLC6A8, alongside 12 X chromosome
control probes and four autosomal control probes. Subse-
quently, MLPA of the FLNA gene was performed using the
P049 kit and included probes for FMR2, IDS, three exons of
PNCK, 10 exons of SLC6A8, three exons of BCAP31, two
exons of ABCD1, IDH3G, four exons of L1CAM, IRAK1,
two exons and one intron of MECP2, three exons of FLNA,
two exons of GDI1, two exons of FVIII and SYBL1,
alongside six chromosome X control probes.
MLPA was performed as follows: 200 ng of DNA was
denatured and hybridised with the probe mix at 601C
overnight. The following morning, the paired probes were
ligated using ligase-65 at 541C for 15 min. This was
followed by a PCR using a common M13 primer pair and
the following PCR conditions; 951C for 30 s, 601C for 30 s
and 721C for 1 min for 35 cycles. The products were run on
an ABI 3130 Genetic Analyser and analysed using the
Genemapper 4.0 software (Applied Biosystems, Foster City,
CA, USA). Data were normalised and analysed by peak
heights, using the analysis spreadsheets from the National
Genetics Reference Laboratory (NGRL, Manchester, UK).
An affected male patient from each of the families 1, 3, 4,
5, 8 and 9 was tested for copy number variations at the
Xq28 region. In family 2, where no DNA was available from
an affected male patient, the mother of cases 1 and 2 was
tested. Where possible, maternal samples were also tested.
Results were confirmed using an Affymetrix SNP analyser
with a 250 kb resolution. Patients from families 6, 7 and 10
were studied by aCGH using an Agilent 44B array at a
























































Figure 2 Schematic representation of the Xq28 region to demonstrate the extent of the duplications in families 1–10. Families 1, 2, 3, 4, 5, 8 and
9 were analysed using MLPA with the PO15C and the PO49 kits. The regions covered by both of these are indicated at the top of the diagram in
relation to the position of known genes within the Xq28 region. The MLPA results in the above families are shown, with filled blocks indicating the
duplicated regions and open blocks indicating normal copy number. When repeated, the MLPA result in family 3 has suggested that some regions may
be triplicated and others duplicated, and this is currently the subject of further investigation. Families 6, 7 and 10 were studied by array CGH using the
Agilent 44B array at a resolution of approximately 100 Mb, and the extent of the duplications is shown in the lower part of the diagram. These varied in
size, the largest being approximately 4 Mb (150.49–154.5), the intermediate 1.3 Mb (152–153.4) and the smallest 650 kb (152.5–153.13).
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Results
Affected male patients in all families had previously been
shown to have normal routine karyotypes. In family 7,
FISH with subtelomeric probes revealed the absence of
signal of the probe DXYS129 (distal PAR1) at Yp and the
presence of three signals of the probe ESTCdYC07, with
two signals at Xq and Yq and a third signal at Yp. The
imbalance was at first interpreted as recombinant chromo-
some [ish der(Y)inv(Y)(p11;q22)(DXYS129ESTCdyC07þ þ )].
Investigation of affected male patients from families 1, 3,
4, 5, 8 and 9 and the mother of family 2 using the PO15C
kit demonstrated duplications in families 1–5. Further
studies using the P049 kit, which also included the FLNA
gene, identified duplications in all of these families
(Figure 2). Patients from families 6, 7 and 10 were shown
to have Xq28 duplications using the Agilent 44B array.
Detailed mapping of the extent of the deletions has not yet
been undertaken. In families 8 and 9, the duplications
involved only the FLNA gene where intragenic duplica-
tions of exons 4 and 11, but not exon 40, were demon-
strated. Affected male patients from each of these two
families had previously been screened for point mutations
within the FLNA gene with negative results. All of these
results were confirmed using the X chromosome SNP array.
Investigation of the available mothers confirmed that the
mothers in families 1, 2, 3, 5, 6 and 10 were obligate
carriers. In family 10, the maternal grandmother and the
mentally retarded sister were also carriers of the same
rearrangement, whereas the unaffected sister did not show
the same imbalance. In families 4 and 7, the duplications
appeared to have arisen de novo as no duplications were
demonstrated in the mother. X-inactivation testing
on blood samples from the female patients in family
10 showed skewed inactivation in all the female patients
carrying the Xq28 duplication, with the inactive
X chromosome being the duplicated one. Further studies
of family 7 failed to define the break points of the Yp
deletion because of the lack of terminal Yp oligonucleo-
tides on the platform used. This rearrangement most likely
involves the distal PAR1 region encompassing the SHOX
gene as the proband has a short stature. FISH analysis using
a specific Xq28 probe (RP11-119A22) confirmed the
translocation of the duplicated region to the short arm of
chromosome Y.
Discussion
Over 50 male patients with duplications of the Xq28 region
have now been reported; several previous authors have
reviewed the sizes of the duplications and commented on
possible correlation between the phenotype and the genes
included in the duplicated regions.4,7 Although spasticity,
severe learning disability, axial hypotonia and frequent
chest infections have been common findings within this
group of patients, gastrointestinal symptoms have been
much rarer. Gastro-oesophageal reflux has been mentioned
as a feature in some patients,3 but other bowel symptoms
have been infrequent. In the report by Meins et al,1 one
patient had suspected gluten enteropathy because of poor
weight gain but no other bowel symptoms.
Many neurological and skeletal phenotypes have been
associated with FLNA mutations.14 Missense mutations,
generally thought to lead to gain of function, cause the
skeletal phenotypes of otopalatodigital syndrome,
Melnick–Needles syndrome and frontometaphyseal dys-
plasia. FLNA loss-of-function mutations are associated with
the PVNH phenotype and are usually embryonically lethal
in male patients.15 Virtually, all of these mutations are
frameshift or truncating and likely to be subject to
nonsense-mediated RNA decay. There have been two
reports of surviving male patients with PVNH associated
with duplications of the Xq28 region,15,16 suggesting that
the amount of FLNA is critical for neuronal migration, and
either increased or decreased expression can interfere with
the normal migration process. This hypothesis is also
supported by animal studies.17
Chronic intestinal pseudo-obstruction has not been a
prominent feature in patients with FLNA mutations who
were ascertained because they had PVNH, and this may be
because they often do not survive. Interestingly, one
heterozygous female patient was noted to have problems
with gastrointestinal motility.15 Surviving male patients
with milder FLNA mutations, where some FLNA function is
retained, have been described18 but again, gastrointestinal
problems were not noted as a prominent feature.
Gargiulo11 studied a family that was ascertained because
of intestinal pseudo-obstruction, and identified a 2-bp
deletion in FLNA. Affected members of this family do not
appear to have been screened for the presence of PVNH.
Although the deletion caused a frameshift, the presence of
an alternative ATG site 22 codons downstream of the
initial ATG enabled the production of a shorter FLNA
protein. The authors thus hypothesised that the first 27
FLNA residues might be crucial for enteric neuron structure
and function. Alternatively, the bowel symptoms could
have resulted from an overall reduced FLN expression.
Hehr19 described a further patient with PVNH and severe
constipation who had an FLNA splice-site mutation
leading to the production of both a normal and a shorter
mRNA. These findings might be consistent with either of
the above hypotheses. FLNA protein expression in our
families has not yet been studied in detail, and thus
suggestions as to how the intestinal phenotype is caused
are purely speculative; one hypothesis is that increased
FLNA dosage significantly compromises enteric neuron
development in addition to affecting neuronal migration.
The findings in Hehr’s patient suggest that the bowel
problems may, like neuronal migration, be affected by both
under- and overexpression of FLNA. Phenotyping of the
reported patients with FLNA mutations or duplications has
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not always been comprehensive. Patients ascertained
through chronic intestinal pseudo-obstruction have not
always been investigated for PVNH and vice versa. Studies
of filamin expression, more detailed phenotyping and
careful scrutiny of the MRI images of patients with both
FLNA mutations and duplications should help to resolve
this issue.
OMIM entry 300048 concerns the phenotype of X-linked
chronic idiopathic intestinal pseudo-obstruction (CIIP)
associated with additional features including patent ductus
arteriosus, short bowel, malrotation and coagulopathy.
This entity includes the family reported by Fitzpatrick
et al12 (our family 8), who had all of the above features,
along with a similar patient reported by Pollock et al.20 Two
further cases were reported by Harris et al,21 and the Italian
family with CIIP originally reported by Aurecchio et al,22
and then investigated by Gargiulo,11 is included. Although
this Italian kindred was subsequently identified to have a
loss-of-function mutation in FLNA, no mutation was
identified in Fitzpatrick’s family or in our family 9. It is
not clear whether FLNA was studied in the patient reported
by Pollock et al.20 The presence of thrombocytopaenia with
large platelets and the absence of a filamin mutation set
these two families apart from Gargiulo’s kindred. Their
duplication detected with the P049 MLPA kit demonstrated
only duplication of exons 4 and 11 of the FLNA gene, and
they were the only patients of our cohort in which
thrombocytopaenia was a feature. Neither of the patients
from families 8 and 9 had mental retardation, hypotonia or
spasticity, and they were not facially so dysmorphic as the
patients with large duplications. Thrombocytopaenia and
cardiac defects are clearly not confined to patients with
intragenic FLNA duplications; however, as Parrini et al23
reported that insufficiency of the aortic valve, PDA or
idiopathic thrombocytopaenia were present in 20 of the 35
patients with FLNA mutations, they ascertained in their
study of PVNH. Vascular events such as cerebrovascular
accidents were also documented in female patients hetero-
zygous for an FLNA mutation and a hemizygous male
patient had a neonatal haemorrhage and maturation arrest
of the bone marrow.15 There is clear demonstration,
therefore, of the association between PVNH, CIIP, cardiac
defects and thrombocytopaenia in patients with FLNA
point mutations and intragenic duplications. A systematic
search for these haematological and vascular features in the
group of patients with larger Xq duplications may help to
delineate the thrombocytopaenia and bone marrow phe-
notype further.
Unger et al24 reported a patient with a missense mutation
in FLNA and a phenotype suggestive of FG syndrome. This
child had presented with relative macrocephaly, an
unusual head shape and severe and chronic constipation.
He had a prominent forehead with a frontal cowlick,
a small mouth and simple unfolded ears. Until recently, FG
syndrome has been considered as a group of genetically
heterogeneous X-linked conditions, and reported affected
male patients have had diverse phenotypes, mainly
including mental retardation, macrocephaly and severe
constipation. Since the finding of MED12 mutations in the
original FG family25 and Unger’s report of an FLNA
mutation, more distinctive phenotypes for FG syndrome
have emerged. It is possible that some of the ‘FG’ patients
without MED12 or FLNA mutations may have FLNA
duplications. Interestingly, FG syndrome had been con-
sidered as a possible diagnosis in family 1.
Few authors have commented in great detail on the
facial gestalt of the Xq28 duplication patients. Gargiulo for
example, concentrated on the intestinal phenotype rather
than including a description or photographs of facial
features. We believe that there is a recognisable face
(Figure 3). Families 1 and 2 were recognised as having the
same syndrome on the basis of facial features as well as
bowel symptoms several years before molecular diagnosis.
Patient 4 was originally referred with a possible diagnosis of
Angelman syndrome, but on the basis of his facial
appearance, MECP2 duplication testing was undertaken.
Most of our patients had a narrow ‘pinched’ appearance of
the nose with a translucent quality of the skin and
prominent veins. The eyes appeared deep-set and the chin
prominent. The lower lip was frequently everted and small;
widely spaced teeth were noted in some patients. A frontal
cowlick was often present. We would agree with
Figure 3 Composite of faces showing, from left to right, two siblings from family 1, one from family 2 and the proband from family 4. All
demonstrate similar hypotonic facies, narrow nose, prominent forehead and deep-set eyes. The mouth and chin are relatively small and the skin is thin
with visible veins.
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Van Esch et al2 that the ears appear prominent and the face
hypotonic, though a flat nasal bridge tended to be present
only in younger patients. Although microcephaly has
frequently been reported with Xq28 duplications, this is
not universally the case and several of our patients had head
circumferences within the normal range even though their
other growth parameters were impaired. This relative macro-
cephaly was associated with a prominent appearance of the
forehead. An asymmetric skull shape has been commented
upon in several patients both within our cohort and in the
literature. Our patients looked remarkably similar to patient 3
of Smyk et al4 and patient II2 reported by Friez
5. The Xq28
facial gestalt seems to be more recognisable from mid-
childhood onwards and less recognisable in patients who
have associated microcephaly. MRI brain scans had been
carried out on several of our patients as detailed above. None
of the patients were reported to have the classical appearance
of PVNH, although abnormal periventricular white matter
was reported in some (see Table 1), and these scans deserve
further scrutiny. Abnormalities of the corpus callosum and
delayed myelination were frequently reported and these
features were also mentioned in the male patient with a
duplication reported by Fox.15
In summary, we propose that duplication of the Xq28
region is a significant cause of intestinal pseudo-obstruc-
tion, especially in male patients presenting with severe
learning difficulties and hypotonia, and that this and the
presence of characteristic facial features are helpful in
recognition of the phenotype. Though Xq28 duplications
will, for the most part, contain several genes, our observa-
tions suggest that it is the involvement of the FLNA gene
that appears to be responsible for the presence of intestinal
pseudo-obstruction. This is corroborated by evidence from
previously reported patients with FLNA mutations and by
animal studies. The occurrence of additional features
including patent ductus arteriosus, short bowel, malrota-
tion, thrombocytopaenia, maturation arrest of the bone
marrow and agenesis of the corpus callosum, in addition to
PVNH and CIIP, suggests that duplication of FLNA is acting
as a hypomorphic mutation with pleiotrophic effects in
affected male patients. Male patients with larger duplica-
tions had the additional neurological features of mental
retardation, hypotonia or spasticity, but it seems feasible
that many of the phenotypic features of the Xq28
duplication may be due to FLNA involvement alone.
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